PH30718A - Improved intravaginal treatment of vaginal infectios with buffered metronidazole compositions. - Google Patents

Improved intravaginal treatment of vaginal infectios with buffered metronidazole compositions.

Info

Publication number
PH30718A
PH30718A PH40620A PH40620A PH30718A PH 30718 A PH30718 A PH 30718A PH 40620 A PH40620 A PH 40620A PH 40620 A PH40620 A PH 40620A PH 30718 A PH30718 A PH 30718A
Authority
PH
Philippines
Prior art keywords
infectios
vaginal
metronidazole
buffered
composition
Prior art date
Application number
PH40620A
Other languages
English (en)
Inventor
Robert J Borgman
Original Assignee
Curatek Pharmaceuticals Ltd Pa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curatek Pharmaceuticals Ltd Pa filed Critical Curatek Pharmaceuticals Ltd Pa
Publication of PH30718A publication Critical patent/PH30718A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PH40620A 1989-06-06 1990-06-05 Improved intravaginal treatment of vaginal infectios with buffered metronidazole compositions. PH30718A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36227389A 1989-06-06 1989-06-06

Publications (1)

Publication Number Publication Date
PH30718A true PH30718A (en) 1997-09-23

Family

ID=23425444

Family Applications (1)

Application Number Title Priority Date Filing Date
PH40620A PH30718A (en) 1989-06-06 1990-06-05 Improved intravaginal treatment of vaginal infectios with buffered metronidazole compositions.

Country Status (21)

Country Link
EP (1) EP0404376B1 (ro)
JP (1) JP2999820B2 (ro)
KR (1) KR0169487B1 (ro)
CN (1) CN1054507C (ro)
AT (1) ATE103176T1 (ro)
AU (1) AU635752B2 (ro)
BR (1) BR9006793A (ro)
CA (1) CA1337279C (ro)
DE (1) DE69007547T2 (ro)
DK (1) DK0404376T3 (ro)
ES (1) ES2062366T3 (ro)
HU (1) HU207795B (ro)
IE (1) IE65413B1 (ro)
IL (1) IL94619A (ro)
PH (1) PH30718A (ro)
PL (1) PL164128B1 (ro)
RO (1) RO109156B1 (ro)
RU (1) RU2032402C1 (ro)
WO (1) WO1990014832A1 (ro)
YU (1) YU47950B (ro)
ZA (1) ZA904413B (ro)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5592949A (en) * 1994-06-29 1997-01-14 Moench; Thomas R. Device for acidic buffering and method for inactivation of pathogens
GB9610359D0 (en) * 1996-05-17 1996-07-24 Edko Trading Representation Pharmaceutical compositions
GB9626513D0 (en) * 1996-12-20 1997-02-05 Bioglan Ireland R & D Ltd A pharmaceutical composition
RU2154477C1 (ru) * 1998-12-10 2000-08-20 Новокузнецкий государственный институт усовершенствования врачей Способ лечения хронического трихомониаза
RU2195943C2 (ru) * 2000-02-14 2003-01-10 Владивостокский государственный медицинский университет Способ лечения гонореи
RU2195945C2 (ru) * 2000-02-14 2003-01-10 Владивостокский государственный медицинский университет Способ лечения инфекций, передаваемых половым путем
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
DE10114244A1 (de) * 2001-03-22 2002-10-02 Heraeus Kulzer Gmbh & Co Kg Antibiotikum-/Antibiotika-Zubereitung mit retardierender Wirkstofffreisetzung
CN1536986B (zh) * 2001-03-27 2012-07-04 沃纳奇尔科特(爱尔兰)有限公司 用于抗微生物剂给药的阴道内药物递送装置
RU2180567C1 (ru) * 2001-05-03 2002-03-20 Новокузнецкий государственный институт усовершенствования врачей Способ лечения хронического рецидивирующего трихомониаза
RU2212238C2 (ru) * 2001-11-05 2003-09-20 Новокузнецкий государственный институт усовершенствования врачей Способ лечения рецидивирующего урогенитального кандидоза на фоне трихомониаза
GB0130666D0 (en) * 2001-12-21 2002-02-06 Accantla Holdings Ltd Absorbent tampons
US6899890B2 (en) 2002-03-20 2005-05-31 Kv Pharmaceutical Company Bioadhesive drug delivery system
RU2221574C2 (ru) * 2002-03-21 2004-01-20 Саратовский государственный медицинский университет Способ лечения хронического трихомонадного эндоцервицита
AU2003234311A1 (en) * 2002-05-01 2003-11-17 Selig Sealing Products, Inc. Warming and nonirritating lubricant antifungal gel compositions
US7695730B2 (en) 2002-05-01 2010-04-13 Mcneil-Ppc, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
US7417013B2 (en) 2002-05-01 2008-08-26 Mcneil-Ppc, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
US7005408B2 (en) * 2002-05-01 2006-02-28 Mcneil-Ppc, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
KR101046538B1 (ko) * 2002-05-01 2011-07-07 맥네일-피피씨, 인코포레이티드 가온성 및 비자극성 무수 윤활제 조성물
US7658941B2 (en) 2002-05-01 2010-02-09 Johnson & Johnson Consumer Companies, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
AU2003279493B2 (en) 2002-10-25 2009-08-20 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
RU2240781C1 (ru) * 2003-06-05 2004-11-27 Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии Способ лечения воспалительных процессов вульвы и влагалища
EP1635847B1 (en) * 2003-06-13 2019-07-31 IDH Holding ApS Treatment of symptoms associated with bacterial vaginosis
RU2236851C1 (ru) * 2003-06-16 2004-09-27 Красноярская государственная медицинская академия Способ местного лечения бактериального вагиноза
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
WO2005027807A1 (en) * 2003-09-19 2005-03-31 Drugtech Corporation Pharmaceutical delivery system
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
RU2249821C1 (ru) * 2004-04-27 2005-04-10 Государственное учреждение "Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского Министерства здравоохранения Российской Федерации" Способ оценки микробиоценоза влагалища
WO2006016869A1 (en) * 2004-07-08 2006-02-16 Drugtech Corporation Delivery system
RU2275918C1 (ru) * 2005-01-11 2006-05-10 ГОУ ВПО "Красноярская государственная медицинская академия Министерства здравоохранения РФ" Способ лечения хронического сальпингоофорита
US7851419B2 (en) 2005-09-12 2010-12-14 Nawaz Ahmad Substantially anhydrous sprayable personal lubricant
US20070059250A1 (en) * 2005-09-12 2007-03-15 Nawaz Ahmad Sprayable personal lubricant
EP1968544A2 (en) * 2006-01-05 2008-09-17 Drugtech Corporation Drug delivery system for bioadhesion to a vulvovaginal surface
WO2007079389A2 (en) * 2006-01-05 2007-07-12 Drugtech Corporation Composition and method of use thereof
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
RU2356535C2 (ru) * 2007-07-23 2009-05-27 Закрытое Акционерное Общество "Биокад" Суппозитории комбинированного действия для лечения инфекционных гинекологических заболеваний (варианты)
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
EP2242476A2 (en) 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
HUE032022T2 (en) * 2009-01-09 2017-08-28 Egyt Gyogyszervegyeszeti Gyar Medicinal product with improved effect
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
MX359879B (es) 2009-10-02 2018-10-12 Foamix Pharmaceuticals Ltd Composiciones tópicas de tetraciclina.
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
RU2428173C1 (ru) * 2010-06-03 2011-09-10 Общество с ограниченной ответственностью "ЦитоНИР" (ООО "ЦитоНИР") Фармацевтическая композиция для лечения заболеваний нижнего отдела мочеполовой системы
BR112013033759B1 (pt) 2011-06-28 2021-05-25 Chemo Research Sl forma de dosagem unitária de um gel de base aquosa de metronidazol mucoadesivo e uso relacionado ao gel de base aquosa de metronidazol
CA2916002A1 (en) 2013-06-25 2014-12-31 Mission Pharmacal Company Novel formulations for the treatment of vaginal disorders
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
RU2730021C1 (ru) * 2019-10-08 2020-08-14 Общество с ограниченной ответственностью "Научно-производственная фирма ВЕРТА" Средство местного применения для лечения инфекционных вагинитов
CN112773780A (zh) * 2019-11-11 2021-05-11 深圳优丽康生物技术有限公司 一种阴道外阴用组合物及其用途
RU2726123C1 (ru) * 2019-12-20 2020-07-09 Федеральное государственное бюджетное учреждение науки Оренбургский федеральный исследовательский центр Уральского отделения Российской академии наук Способ лечения трихомониаза у женщин
US11529346B2 (en) * 2020-06-18 2022-12-20 National Medical Supply, LLC Vaginal gel
CA3184425A1 (en) * 2020-06-30 2022-01-06 Mark C. Faulkner Compositions for controlling odor and itch and methods of and devices for administering same
CN115737551B (zh) * 2022-12-06 2025-08-05 天津市保灵动物保健品有限公司 一种氟苯尼考甲硝唑滴耳液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0024023B2 (de) * 1979-08-11 1992-11-11 Bayer Ag Antimykotische Mittel mit höherer Freisetzung der Wirkstoffe
US4602040A (en) * 1983-04-18 1986-07-22 Warner-Lambert Company Meclofenamic acid topical pharmaceutical composition
US4837378A (en) * 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
GB8607159D0 (en) * 1986-03-22 1986-04-30 Smith & Nephew Ass Pharmaceutical composition
SE8603338D0 (sv) * 1986-08-07 1986-08-07 Bjorn Andersch Medel for behandling av tillstand i slidan

Also Published As

Publication number Publication date
HU904720D0 (en) 1991-07-29
JP2999820B2 (ja) 2000-01-17
RU2032402C1 (ru) 1995-04-10
CA1337279C (en) 1995-10-10
JPH04500365A (ja) 1992-01-23
HUT56490A (en) 1991-09-30
YU170090A (sh) 1994-04-05
WO1990014832A1 (en) 1990-12-13
AU635752B2 (en) 1993-04-01
AU5829490A (en) 1991-01-07
DE69007547T2 (de) 1994-07-14
IE902011L (en) 1990-12-06
IE65413B1 (en) 1995-10-18
BR9006793A (pt) 1991-08-06
PL164128B1 (pl) 1994-06-30
DE69007547D1 (de) 1994-04-28
ATE103176T1 (de) 1994-04-15
DK0404376T3 (da) 1994-05-24
IL94619A0 (en) 1991-04-15
CN1049101A (zh) 1991-02-13
RO109156B1 (ro) 1994-12-30
PL285507A1 (en) 1992-01-13
HU207795B (en) 1993-06-28
IL94619A (en) 1995-01-24
EP0404376A2 (en) 1990-12-27
EP0404376A3 (en) 1991-06-05
KR0169487B1 (ko) 1999-01-15
EP0404376B1 (en) 1994-03-23
ES2062366T3 (es) 1994-12-16
CN1054507C (zh) 2000-07-19
KR920700032A (ko) 1992-02-19
ZA904413B (en) 1991-04-24
YU47950B (sh) 1996-07-24

Similar Documents

Publication Publication Date Title
PH30718A (en) Improved intravaginal treatment of vaginal infectios with buffered metronidazole compositions.
US5905092A (en) Topical antibiotic composition providing optimal moisture environment for rapid wound healing that reduces skin contraction
EP0266968A3 (en) Gelled ointment of vasodilating agent
CN113999406A (zh) 一种多功能抗菌水凝胶敷料的制备方法及应用
ES2044894T3 (es) Poliuretanos solubles o dispersables en agua, un procedimiento para su fabricacion y su utilizacion para el recubrimiento de substratos discrecionales.
IL101269A0 (en) Tacky hydrophilic gel dressings and their preparation
YU89683A (en) Method of preparing a pharmaceutically or veterinary acceptable amphipathic non-crosslinked linear, branched or graft block-copolymer
IE812025L (en) Composition for treating osteitis
AU1223199A (en) Pharmaceutical formulation for stimulating the growth of gram-positive bacilli and increasing the acidity in vagina and the use thereof
EP0489108A4 (en) Method and composition for the treatment of cutaneous, ocular, and mucosal hypersensitivity, inflammation, and hyperproliferative conditions using topical preparations of serotonin antagonists
CA2159730A1 (en) Ionene polymers as anthelmintics in animals
KR900012617A (ko) 혈전증 치료제 및 그 제조방법
AU2002350115A1 (en) Medical compositions for intravesical treatment of bladder cancer
ES8302742A1 (es) Procedimiento para preparar polimeros organicos sililados
SE8603338D0 (sv) Medel for behandling av tillstand i slidan
EP0305744A3 (en) Quinoline, naphthyridine and benzoxazine-carboxylic acid derivatives and their use as antibacterial agents
GR3036822T3 (en) Eye lotion in particular for dry eye treatment
FR2452861A1 (fr) Semences enrobees et procede pour l'enrobage des semences
ES8705900A1 (es) Procedimiento para producir un polimero de formacion de hi- drogel
EP0309028A3 (en) Substituted thieno(2,3-b)furan-2-sulfonamides as antiglaucoma agents
UA13697A1 (uk) Спосіб передпосівhої обробки hасіhhя
Schleicher et al. Perioperative antibiotic prophylaxis in vascular surgery.
EP0093484A3 (en) Antibacterial monic acid derivatives
MY106605A (en) Compositions for the treatment of leishmaniasis
UA39654A (uk) Спосіб дренування гнійних ран